broadspectrum
antivir
arbidol
arb
inhibit
cell
entri
envelop
virus
block
viral
fusion
host
cell
membran
better
understand
arb
mechan
action
investig
interact
phospholipid
membran
peptid
demonstr
arb
associ
phospholipid
micromolar
rang
nmr
reveal
arb
interact
polar
headgroup
phospholipid
membran
interfac
fluoresc
studi
interact
arb
either
tryptophan
deriv
membran
peptid
reconstitut
liposom
show
arb
interact
tryptophan
micromolar
rang
interestingli
appar
bind
affin
lipid
tryptophan
residu
compar
arb
hepat
c
viru
hcv
membran
fusion
sinc
tryptophan
residu
membran
protein
known
bind
preferenti
membran
interfac
data
suggest
arb
could
increas
strength
viru
glycoprotein
interact
membran
due
dual
bind
mode
involv
aromat
residu
phospholipid
result
complex
would
inhibit
expect
viral
glycoprotein
conform
chang
requir
fusion
process
find
pave
way
toward
design
new
drug
exhibit
arblik
interfaci
membran
bind
properti
inhibit
earli
step
viru
entri
ie
attract
target
combat
viral
infect
distinct
specif
antivir
compound
target
key
viral
function
group
broadspectrum
medicin
drug
origin
design
treatment
target
toward
number
virus
review
advantag
group
antivir
alreadi
met
pharmacolog
criteria
medicin
drug
alreadi
approv
clinic
use
countri
among
molecul
antivir
agent
target
viral
entri
envelop
virus
major
interest
sinc
seiz
earli
step
viral
life
cycl
damag
occur
cell
recent
review
sinc
incorpor
combin
multipl
drug
differ
target
one
compound
arbidol
arb
acid
dimethylamino
methyl
phenylthio
methyl
ethyl
ester
monohydrochlorid
ca
registri
number
figur
alreadi
licens
russia
china
describ
antiinfluenza
drug
immunostimul
properti
arb
use
sever
year
prophylaxi
treatment
influenza
b
infect
inhibit
influenza
virusinduc
membran
fusion
may
capac
induc
serum
interferon
recent
studi
extend
inhibitori
activ
human
virus
respiratori
syncyti
viru
parainfluenza
viru
rhinoviru
hepat
b
viru
review
demonstr
also
inhibit
hepat
c
viru
hcv
infect
vitro
hcv
replic
hcv
cell
entri
membran
fusion
use
hcv
pseudoparticl
hcvpp
hcv
grown
cell
cultur
hcvcc
recent
ciliberto
cowork
demonstr
efficaci
arb
deriv
inhibit
hcv
entri
replic
hepatoma
cell
low
micromolar
rang
hcv
infect
lead
caus
liver
diseas
includ
hepatocellular
carcinoma
therapeut
option
still
limit
recent
review
see
ref
therein
thu
urgent
need
develop
effici
well
toler
drug
combat
viru
arb
demonstr
propens
enter
hydrophob
interact
membran
membranelik
environ
deterg
micel
character
mechan
action
arbidol
analyz
molecular
atom
level
interact
arb
membran
tryptophanrich
deriv
peptid
first
examin
arb
inhibit
hcv
entri
membran
fusion
use
hcvpp
differ
genotyp
found
arb
inhibit
genotypeindepend
combin
surfac
plasmon
reson
fluoresc
nmr
spectroscopi
approach
show
arb
directli
interact
phospholipid
membran
interfac
affin
micromolar
rang
compar
concentr
inhibit
hcvpp
membran
fusion
arb
also
display
micromolar
affin
toward
aromat
compon
protein
tryptophan
deriv
toward
peptid
contain
tryptophan
deriv
hcv
envelop
glycoprotein
altogeth
result
demonstr
arb
interact
polar
head
phospholipid
membran
protein
motif
enrich
aromat
residu
suggest
inhibitori
activ
arb
hcv
entri
fusion
could
involv
type
interact
phosphatidylcholin
egg
yolk
pc
pure
dimyristoylphosphatidylcholin
dmpc
pure
cholesterol
chol
pure
lysophosphatidylcholin
lysopc
dodecylphosphocholin
dpc
triton
tryptophan
octyl
ester
hydrochlorid
toe
nacetylltryptophanamid
nata
purchas
sigma
octadecyl
rhodamin
b
chlorid
r
molecular
probe
peptid
use
part
sequenc
structur
non
structur
ns
protein
hcv
bovin
viral
diarrheal
viru
bvdv
amphiphil
helix
bvdv
transmembran
domain
hcv
obtain
describ
previous
peptid
identifi
import
hcv
fusion
purchas
clonstar
biotech
puriti
sigma
genosi
puriti
respect
dissolv
dmso
prepar
lipid
peptid
mixtur
arbidol
arb
acid
dimethylamino
methyl
phenylthio
methyl
ethyl
ester
monohydrochlorid
figur
kind
gift
stephen
j
polyak
arb
readili
solubl
ethanol
solubl
mm
rang
water
ethanol
stock
solut
arb
dilut
mm
final
concentr
milliq
water
final
stock
solut
contain
ethanol
spr
experi
one
mg
arb
resuspend
water
follow
centrifug
min
arb
concentr
solut
measur
nm
supernat
arb
extinct
coeffici
cm
solvent
evapor
sampl
resuspend
phosphatebuff
salin
pb
ph
water
underw
freezethaw
cycl
liquid
nitrogen
respect
liposom
prepar
extrus
stack
avestin
polycarbon
filter
nm
describ
cell
maintain
dmem
contain
g
l
dglucos
mm
lglutamin
invitrogen
cergypontois
franc
supplement
uml
penicillin
mgml
streptomycin
fc
lonza
product
pseudotyp
virus
obtain
transient
transfect
cell
calciumphosph
method
genotyp
studi
hcvpp
genotyp
produc
describ
previous
cell
cotransfect
murin
leukemia
viru
mlv
gagpol
packag
construct
mlvbase
transfer
vector
encod
gfp
marker
protein
express
construct
supernat
collect
posttransfect
filter
mm
genotyp
pseudoparticl
concentr
ultracentrifug
sucros
cushion
pellet
resuspend
regular
medium
cell
infect
experi
cell
seed
cellswel
plate
follow
day
cell
infect
presenc
increas
arb
concentr
h
arbidol
effect
viral
infect
evalu
assay
gfp
activ
hour
infect
use
flow
cytometri
facscalibur
pseudoparticl
harbour
surfac
influenza
hemagglutinin
happ
envelop
glycoprotein
felin
oncoviru
prepar
describ
respect
lipid
mix
pseudoparticl
pc
chol
r
liposom
monitor
fluoresc
spectroscopi
dequench
r
brief
r
note
number
panel
refer
proton
number
identifi
nmr
cf
figur
tabl
ha
incub
min
fusion
initi
acidif
ph
hcl
record
slm
aminco
spectrofluorimet
time
period
excit
emiss
wavelength
nm
nm
respect
maxim
r
dequench
measur
addit
triton
final
concentr
cuvett
lyse
liposom
procedur
use
follow
pseudoparticl
fusion
presenc
arb
case
incub
pseudoparticl
liposom
arb
mm
final
concentr
ad
incub
min
fusion
initi
acidif
indol
emiss
fluoresc
spectra
tryptophan
deriv
record
excit
wavelength
nm
spectral
zone
lowest
absorpt
arb
variou
condit
nata
mm
final
pb
ph
toe
mm
lysopc
micel
toe
lysopc
molar
ratio
pc
pc
chol
liposom
toe
lipid
molar
ratio
peptid
mm
pc
chol
liposom
peptid
lipid
molar
ratio
spectra
obtain
absenc
presenc
increas
concentr
arb
mm
sampl
incub
min
prior
record
emiss
spectra
collect
nm
region
nmincrement
blank
substract
use
black
flatbottom
lowbind
micropl
greiner
bioon
measur
record
tecan
infiniteh
spectrofluorimet
k
app
valu
calcul
differ
area
spectra
absenc
presenc
arb
da
variou
arb
concentr
nonlinear
fit
use
equat
da
da
max
c
k
c
fluoresc
measur
repeat
three
time
obtain
averag
valu
k
app
guv
made
electroform
method
flow
chamber
warner
instrument
connecticut
usa
use
vesicl
prepar
equip
two
glass
coverslip
coat
optic
transpar
electr
conduct
indium
tin
oxid
ito
philip
eindhoven
nl
mixtur
lipid
pc
chol
r
molar
ratio
prepar
mm
chloroform
lipid
mixtur
nmole
spread
thin
uniform
film
conduct
face
itoco
slide
chloroform
evapor
dri
lipid
film
hydrat
ad
water
chamber
ml
altern
electr
field
hz
appli
room
temperatur
hour
guv
absenc
presenc
increas
amount
arb
solubil
water
nmole
observ
epifluoresc
microscopi
interact
arb
dmpc
layer
investig
biacor
use
sensor
chip
sensor
chip
surfac
wash
mixtur
mm
naoh
isopropanol
v
v
flow
rate
mlmin
min
run
buffer
milliq
water
influenc
liposom
concentr
final
spr
signal
test
assay
lipid
concentr
mm
measur
result
reson
unit
ru
obtain
well
detect
reproduc
stabl
signal
mm
increas
concentr
improv
signal
therefor
chose
mm
concentr
experi
dmpc
liposom
resuspend
milliq
water
captur
sensor
chip
mlmin
min
flow
rate
increas
mlmin
liposom
surfac
wash
mm
naoh
min
liposom
immobil
chip
surfac
gave
approx
ru
signal
calcul
arb
affin
lipid
associ
dissoci
dmpc
layer
studi
differ
arb
concentr
water
mm
flow
rate
mlmin
bind
cycl
sensor
surfac
regener
origin
matrix
inject
mm
naoh
isopropanol
v
v
sensor
surfac
coat
fresh
liposom
suspens
next
bind
cycl
k
valu
calcul
equilibrium
reson
signal
r
eq
function
analyt
concentr
r
eq
valu
estim
extrapol
infinit
time
use
plot
reson
signal
function
reciproc
time
appar
k
calcul
nonlinear
fit
express
r
eq
r
max
c
k
c
r
max
maximum
bind
capac
surfac
c
analyt
concentr
use
sigmaplot
softwar
nmr
studi
bicellar
system
prepar
anoth
sampl
similar
lipid
concentr
higher
arb
content
molar
ratio
also
prepar
amount
free
arb
arb
dmpc
mixtur
estim
rapid
separ
lipid
ultrafiltr
membran
cutoff
da
measur
arb
concentr
ultrafiltr
nm
arb
dmpc
molar
ratio
neutral
ph
free
arb
found
lower
thu
conclud
amount
free
arb
nmr
sampl
neglig
h
nmr
experi
perform
bruker
dmx
spectromet
oper
proton
frequenc
mhz
spectra
record
mm
tripl
reson
invers
txi
probe
equip
zgradient
puls
ms
recycl
delay
solvent
suppress
presatur
use
h
spectra
measur
acquir
scan
spectra
use
assign
drug
signal
togeth
noesi
h
c
hsqc
spectra
data
shown
assign
lipid
reson
deriv
comparison
data
literatur
time
measur
use
invers
recoveri
experi
interpuls
delay
rang
ms
measur
repeat
time
ad
scan
delay
time
scan
spectra
process
use
matnmr
h
frequenc
scale
given
term
chemic
shift
rel
aceton
signal
use
extern
refer
ppm
previous
shown
arb
could
inhibit
cell
entri
membran
fusion
hcvpp
genotyp
hcvcc
genotyp
sought
investig
effect
arb
major
hcvpp
genotyp
well
hcvpp
infect
toward
cell
objectifi
hcvpp
entri
assay
count
cell
posit
gfp
marker
protein
incub
without
increas
arb
concentr
see
materi
method
repres
data
set
shown
figur
inhibit
obtain
highest
concentr
arb
mm
present
figur
inhibitori
effect
arb
hcvpp
cell
entri
depend
hcvpp
genotyp
inde
within
biolog
intrins
variabl
hcvpp
prepar
sampl
three
case
could
distinguish
entri
hcvpp
genotyp
inhibit
ca
exhibit
inhibit
entri
genotyp
weakli
affect
presenc
arb
fig
influenc
arb
hcvppmediat
lipid
mix
assay
fluoresc
spectroscopi
use
fluoresc
liposom
previous
describ
lipid
mix
hcvpp
liposom
observ
low
ph
optim
ph
presenc
increas
arb
concentr
lipid
mix
inhibit
arb
dosedepend
manner
figur
hcvpp
genotyp
contrast
observ
hcvpp
infect
effect
mm
arb
hcvppmediat
membran
fusion
figur
similar
test
genotyp
inhibit
membran
fusion
activ
indic
membran
fusion
inhibit
arb
genotypedepend
data
suggest
differenti
inhibitori
effect
arb
hcvpp
infect
variou
genotyp
like
due
genotypedepend
modul
hcv
glycoprotein
interact
cellular
protein
eg
hcv
receptor
involv
hcv
cell
entri
convers
arb
inhibit
hcvpp
membran
fusion
assess
vitro
model
system
protein
present
viral
glycoprotein
could
mere
reflect
interact
arb
lipid
andor
motif
present
hcv
glycoprotein
genotyp
test
hypothes
investig
arb
interact
properti
lipid
protein
fragment
use
approach
describ
follow
previous
show
arb
could
interact
liposom
membranelik
environ
deterg
micel
investig
featur
studi
interact
arb
giant
unilamellar
liposom
guv
optic
microscopi
figur
guv
pure
lipid
bilay
intrins
flexibl
unstabl
due
larg
size
rang
ten
mm
increas
arb
concentr
ad
chamber
guv
compos
pc
chol
electroform
see
method
section
arbtolipid
molar
ratio
guv
bilay
unaffect
presenc
arb
arbtolipid
ratio
occasion
membran
flicker
fig
asterisk
fig
higher
ratio
membran
inhomogen
invagin
appear
fig
asterisk
fig
major
overal
membran
reorgan
observ
arbtolipid
ratio
fig
note
lysi
membran
disloc
guv
observ
happ
present
control
pseudoparticl
sensit
arbidol
cf
also
insensit
arbidol
cf
also
mutant
hcvpp
cf
present
neg
control
entri
display
low
infect
b
membran
fusion
hcvpp
r
label
liposom
measur
record
kinet
lipid
mix
fluoresc
spectroscopi
excit
emiss
wavelength
nm
respect
describ
materi
method
section
valu
last
fusion
kinet
final
extent
fusion
use
calcul
percentag
fusion
presenc
arb
rel
fusion
kinet
without
arb
result
mean
sem
separ
experi
happ
mutant
hcvpp
taken
control
fusion
observ
condit
even
highest
ratio
data
shown
result
reveal
high
concentr
arb
respect
lipid
could
significantli
perturb
lipid
organ
bilay
also
indic
direct
interact
arb
lipid
bilay
concentr
use
inhibit
hcvpp
infect
membran
fusion
panel
e
perturb
lipid
organ
addit
hcvpp
preincub
neutral
acid
ph
arb
even
high
concentr
mm
display
similar
morpholog
visual
transmiss
electron
microscopi
observ
absenc
drug
data
shown
inde
count
hcvpp
condit
differ
hcvpp
morpholog
could
observ
paramet
assess
indic
arb
inhibit
hcvpp
fusion
due
viral
particl
disruptiondamag
gain
insight
molecular
detail
interact
arb
lipid
membran
next
investig
lipid
bind
properti
arb
use
surfac
plasmon
reson
spr
biacoreh
technolog
use
biacor
sensor
chip
captur
dmpc
liposom
sensor
chip
display
lipophil
group
attach
surfac
carboxymethyl
dextran
layer
shown
provid
quick
reproduc
method
prepar
bilayermimet
system
first
test
whether
arbidol
per
se
could
bind
chip
arb
mm
highest
concentr
relev
biolog
context
inject
onto
chip
devoid
liposom
led
approx
reson
unit
ru
see
method
section
dmpc
liposom
mm
captur
onto
sensor
chip
reach
ru
ru
seen
arb
puls
onto
liposomeco
chip
bind
arbidol
alon
chip
remain
therefor
neglig
measur
arbdmpc
associ
dissoci
perform
variou
arb
concentr
rang
mm
passag
surfac
sensor
chip
arb
bound
immobil
dmpc
concentrationdepend
manner
figur
arb
initi
bind
fast
slow
without
reach
satur
equilibrium
stop
arb
flow
onto
sensor
chip
bound
arb
rapidli
incomplet
dissoci
dmpc
membran
inde
arb
concentr
test
arb
remain
bound
dmpc
demonstr
arb
capabl
interact
lipid
membran
stabl
associ
arb
dmpc
howev
behaviour
arb
bind
membran
render
difficult
fit
kinet
model
data
henc
determin
reliabl
onand
offrat
inde
use
global
fit
bind
curv
could
fit
properli
differ
model
includ
biaevalut
softwar
langmuir
bind
bival
analyt
heterog
neou
ligand
heterogen
analyt
conform
chang
without
mass
transport
furthermor
equilibrium
reach
associ
phase
direct
use
scatchard
analysi
calcul
appar
equilibrium
dissoci
constant
allow
instead
appar
equilibrium
dissoci
constant
k
calcul
equilibrium
reson
signal
r
eq
function
analyt
concentr
r
eq
valu
estim
extrapol
infinit
time
use
plot
reson
signal
function
reciproc
time
appar
k
calcul
nonlinear
fit
express
r
eq
r
max
c
k
c
r
max
maximum
bind
capac
surfac
c
analyt
concentr
use
sigmaplot
softwar
calcul
perform
separ
experi
gave
appar
k
mm
see
inset
figur
repres
experi
dissoci
constant
order
hcvpp
fusion
mm
result
indic
inhibitori
effect
arb
hcvpp
membran
fusion
least
part
deriv
arb
associ
lipid
membran
nmr
spectroscopi
use
character
arb
insert
model
membran
system
h
nmr
spectrum
arb
record
k
deuter
water
shown
figur
black
spectrum
assign
proton
signal
deduc
spectra
analysi
data
shown
report
tabl
order
studi
arb
membranemimet
environ
use
isotrop
phospholipid
bicel
consist
mixtur
dmpcdhpc
water
longchain
phospholipid
molecul
dmpc
selfassembl
planar
bilay
shortchain
molecul
dhpc
segreg
edg
region
high
curvatur
bicel
dmpc
dhpc
molar
ratio
form
fast
isotrop
tumbl
aggreg
amen
solut
nmr
studi
still
isotrop
bicel
system
use
phospholipid
bilay
mimet
sinc
dmpc
shown
form
flat
bilay
surfac
h
nmr
spectrum
arb
bicellar
phase
shown
figur
red
spectrum
system
spectral
crowd
due
presenc
phospholipid
reson
allow
observ
proton
denot
arbidol
molecul
see
fig
signal
distinguish
three
proton
addit
h
reson
could
resolv
h
noesi
spectra
h
c
hsqc
spectra
figur
correspond
chemic
shift
shown
tabl
togeth
assign
proton
line
arb
water
arbidol
interact
lipid
induc
chemicalshift
chang
arb
reson
compar
observ
water
order
investig
immers
depth
arb
membran
monitor
proton
longitudin
relax
rate
arb
proton
upon
addit
solubl
paramagnet
agent
gadoliniumdiethylenetriamin
pentaacet
acidbismethylamid
gd
dtpabma
paramagnet
contrast
agent
stay
solubl
water
surround
membran
induc
paramagnet
relax
enhanc
pre
spin
atom
close
surfac
membran
recent
pre
effect
due
gd
dtpabma
use
probe
immers
depth
orient
antimicrobi
peptid
measur
proton
relax
time
arb
phospholipid
proton
probe
immers
depth
arb
membran
use
pre
valu
phospholipid
approxim
yardstick
titrat
arb
gd
dtpabma
perform
increas
concentr
paramagnet
agent
mm
step
titrat
proton
relax
time
proton
arb
proton
alpha
beta
gamma
phospholipid
measur
plot
figur
show
relax
time
function
gd
dtpabma
concentr
titrat
lead
curv
proton
whose
slope
correspond
pre
valu
shown
fig
pre
measur
arbbicel
system
rang
sec
sec
phospholipid
proton
sec
sec
arb
proton
pre
observ
spin
describ
overal
relax
enhanc
due
paramagnet
agent
solut
planar
membran
surround
buffer
contain
noninteract
paramagnet
probe
total
pre
nucleu
immers
depth
given
equat
pre
zd
immers
depth
specif
nucleu
within
membran
plu
radiu
magnet
probe
constant
z
combin
variou
paramet
among
correl
time
combin
electron
relax
time
lifetim
intermolecular
adduct
bicellegd
dtpabma
rotat
correl
time
order
determin
immers
depth
arb
instead
determin
z
use
phospholipid
yardstick
compar
pre
one
arb
pre
resolv
signal
arb
phospholipid
report
compar
figur
procedur
base
two
assumpt
amount
free
arb
solut
presenc
lipid
neglig
see
nmr
sampl
prepar
experiment
procedur
section
therefor
affect
significantli
pre
arb
membran
ii
constant
z
lipid
arb
figur
show
methyl
proton
arb
lipid
water
interfac
gammaproton
hydrophil
headgroup
lipid
proton
arb
level
respect
proton
alpha
phospholipid
aromat
proton
buri
proton
arb
close
begin
hydrophob
chain
proton
valid
assumpt
ii
support
noe
crosspeak
detect
proton
arb
glycerol
moieti
phospholipid
addit
maximum
pre
measur
arb
proton
phospholipid
c
proton
suggest
correspond
molecul
region
expos
water
estim
immers
depth
arb
proton
rel
phospholipid
proton
enabl
us
propos
model
posit
arb
membran
shown
figur
nmr
data
clearli
demonstr
arb
interact
membran
interfac
mainli
level
phospholipid
polar
head
result
support
assumpt
arb
inhibitori
effect
hcvpp
membran
fusion
depend
least
part
interact
second
possibl
regard
arb
activ
arb
might
interact
key
motif
present
viral
protein
therebi
imped
structur
reorgan
onset
fusion
thu
lead
fusion
inhibit
first
set
experi
design
investig
whether
order
addit
fuse
partner
would
affect
arbinduc
fusion
inhibit
purpos
measur
fusion
preincub
hcvpp
liposom
absenc
presenc
mm
arb
shown
tabl
arb
preincub
partner
fusion
initi
lower
ph
fusion
inhibit
ca
contrast
ca
fusion
inhibit
observ
arb
preincub
either
hcvpp
liposom
greater
inhibitori
effect
arb
simultan
access
viral
target
membran
suggest
arb
could
also
act
interact
select
residu
hcv
glycoprotein
sequenc
assumpt
test
studi
interact
behaviour
arb
tryptophan
trp
deriv
tryptophan
constitu
protein
often
found
region
locat
close
membran
interfac
stem
region
sever
viral
fusion
protein
eg
hiv
also
reason
arb
indol
deriv
might
interact
tryptophan
tyrosin
residu
aromat
ring
stack
purpos
test
effect
increas
concentr
arb
fluoresc
nacetyl
tryptophanamid
nata
watersolubl
trp
deriv
tryptophan
octylest
toe
membranotrop
molecul
figur
fluoresc
nata
toe
record
nm
use
excit
wavelength
nm
correspond
absorpt
minimum
arb
result
present
tabl
figur
tabl
similarli
k
arb
toe
lysopc
micel
mm
rang
ph
indic
arb
abl
interact
indol
ring
rel
low
affin
contrast
arb
ad
toe
associ
liposom
toelipid
molar
ratio
mark
increas
affin
observ
tabl
compar
toemicel
toe
liposom
reach
k
valu
mm
rang
note
toe
fluoresc
could
measur
dpc
micel
due
great
intrins
fluoresc
dpc
use
experi
interestingli
k
valu
compar
arb
inhibit
hcvpp
fusion
see
discuss
section
indol
fluoresc
decreas
arb
concentr
increas
virtual
measur
fluoresc
mm
arb
figur
confirm
arb
interact
indol
ring
higher
affin
indol
incorpor
lipid
membran
affin
higher
pc
pc
chol
liposom
tabl
neutral
acid
ph
tabl
figur
acid
ph
arb
like
proton
lipid
environ
probabl
toe
well
arb
affin
toe
condit
might
lower
uncharg
arb
neutral
ph
repuls
electrostat
interact
third
set
experi
design
assess
behaviour
arb
presenc
aromat
residu
protein
sequenc
specif
toward
trp
present
peptid
purpos
use
synthet
membranebind
peptid
known
structur
contain
one
tryptophan
residu
expect
local
membran
interfac
transmembran
helix
hcv
protein
ntermin
amphipath
helix
bvdv
protein
interact
inplan
membran
interfac
intrins
tryptophan
fluoresc
peptid
monitor
presenc
increas
concentr
arb
illustr
figur
hcv
peptid
insert
pc
chol
liposom
figur
bvdv
peptidetolipid
molar
ratio
arb
dosedepend
quench
tryptophan
fluoresc
neutral
acid
ph
clearli
indic
arb
interact
peptid
inset
figur
fig
peptid
ph
red
shift
spectral
maximum
proport
arb
concentr
accompani
fluoresc
quench
effect
pronounc
acid
ph
nm
ph
mm
arb
nm
ph
mm
arb
red
shift
suggest
arb
interact
peptid
reloc
tryptophan
residu
shallow
zone
membran
trp
environ
would
hydrophil
measur
appar
affin
arb
peptid
insert
pc
chol
liposom
perform
describ
interestingli
arb
display
appar
k
toward
peptid
trp
mm
tabl
twice
lower
observ
toe
pc
chol
liposom
sinc
peptid
contain
one
two
tyrosin
residu
hcv
bvdv
respect
addit
trp
interact
arb
molecul
aromat
residu
might
account
higher
affin
arb
peptid
small
molecul
toe
sinc
arb
inhibitor
hcv
membran
fusion
reason
might
interact
region
describ
import
hcv
fusion
peptid
describ
membranotrop
model
membran
contain
aromat
residu
therefor
analyz
effect
increas
concentr
arb
fluoresc
quench
two
peptid
sequenc
deriv
hcv
posit
see
aa
sequenc
tabl
insert
pc
chol
liposom
peptidetolipid
molar
ratio
note
also
test
third
peptid
locat
posit
contain
one
tyr
fluoresc
quantum
yield
low
monitor
interpret
fluoresc
signal
data
shown
calcul
k
valu
describ
shown
tabl
contain
one
trp
wherea
contain
one
trp
tyr
appar
affin
mm
rang
ph
peptid
reminisc
arb
hcvpp
fusion
indic
arb
abl
interact
aromat
residu
peptid
membran
lend
support
hypothesi
arb
could
interact
key
residuesmotif
viral
fusion
protein
would
constitut
possibl
partial
explan
inhibit
hcvpp
fusion
strikingli
affin
decreas
acid
ph
peptid
even
drastic
mm
interestingli
rel
high
k
valu
reminisc
observ
arb
interact
nata
solut
tabl
suggest
interact
peptid
membran
would
weak
acid
ph
peptid
could
solut
moreov
histidin
residu
locat
immedi
vicin
trp
sequenc
peptid
expect
charg
ph
sinc
arb
also
proton
ph
valu
could
creat
repuls
forc
affect
interact
trp
arb
moreov
proton
histidin
cycl
expect
decreas
free
energi
partit
lipid
water
peptid
could
releas
membran
acid
ph
possibl
relat
peptid
conform
chang
behavior
favor
direct
role
fusion
peptid
hcv
viru
depend
low
ph
membran
fusion
activ
howev
due
membranotrop
sinc
studi
show
involv
hcv
membran
fusion
possibl
conform
chang
might
undergo
low
ph
would
lead
proper
reloc
actual
fusion
peptideloop
toward
target
membran
see
discuss
section
studi
aim
investig
molecular
mechan
action
arbidol
arb
inhibit
viru
cell
entri
membran
fusion
use
hcvpp
model
envelop
viru
show
arb
display
dual
bind
capac
lipid
membran
interfac
one
hand
aromat
residu
tabl
tryptophan
protein
hand
therefor
appear
plausibl
observ
inhibitori
effect
arb
viral
entri
membran
fusion
might
result
combin
effect
bind
arb
membran
fusion
protein
physicochem
point
view
arb
display
tropism
membran
membranelik
environ
deterg
micel
particularli
promin
low
ph
combin
sever
biochem
approach
show
arb
propens
bind
incorpor
lipid
bilay
calcul
appar
affin
similar
rang
valu
fusion
ie
ca
mm
nmr
studi
arb
interact
dmpc
lead
model
arb
bind
membran
interfac
establish
contact
mainli
polar
head
phospholipid
fig
altogeth
data
suggest
least
part
arb
inhibitori
activ
could
explain
membranotrop
physicochem
properti
emphas
recent
work
villalain
use
fouriertransform
infrar
spectroscopi
arb
interact
phospholipid
would
disturb
membran
fluiditi
crucial
fusion
process
therebi
render
lipid
bilay
less
prone
fusion
model
consist
behavior
indol
deriv
shown
exhibit
prefer
membran
interfac
due
flat
rigid
structur
molecul
aromat
allow
establish
cationp
interact
posit
charg
quaternari
ammonium
lipid
headgroup
low
ph
optim
ph
hcv
fusion
interact
would
favor
due
proton
amino
group
describ
substitut
indol
possibl
proton
carbon
bear
ester
group
arb
could
displac
group
indol
plane
place
better
posit
bond
neighbor
molecul
could
turn
lead
better
membran
associ
arb
might
therefor
propens
intercal
lipid
viral
target
membran
adopt
consist
orient
fill
gap
lipid
molecul
interfaci
region
lipid
bilay
provid
suitabl
environ
wide
rang
chemic
group
long
possess
larg
enough
hydrophob
moieti
group
capabl
form
hydrogen
bond
lipid
carbonyl
group
sever
compound
antivir
pharmacolog
properti
belong
categori
particular
adamantan
activ
influenza
virus
hcv
clone
natur
triterpen
glycyrrhizin
effici
treatment
chronic
viral
hepatit
flavonolignan
molecul
compos
silymarin
herbal
extract
potent
antihcv
activ
previou
studi
notic
arb
inhibit
cell
entri
concern
hcvpp
pseudoparticl
bear
influenza
hemagglutinin
happ
pseudoparticl
bear
envelop
glycoprotein
felin
oncogen
retroviru
data
suggest
arb
might
display
select
recognit
key
motif
insid
envelop
protein
hypothesi
test
assess
influenc
arb
fluoresc
properti
aromat
compound
deriv
tryptophan
trp
peptid
contain
trp
trp
compon
protein
interfaci
properti
often
locat
lipidwat
interfac
group
socal
tryptophanrich
motif
crucial
proteinmembran
associ
found
envelop
fusion
protein
sar
coronaviru
trp
also
enrich
proteinprotein
bind
interfac
small
envelop
protein
hepat
b
viru
membran
protein
gener
demonstr
arb
abl
alterquench
fluoresc
properti
small
trp
deriv
solut
nata
deterg
micel
liposom
toe
dosedepend
manner
occur
like
stack
aromat
ring
molecul
often
involv
stabil
interc
interestingli
appar
affin
arbtrp
deriv
interact
order
lipid
bilayersmicellessolut
indic
arb
bind
strength
trp
could
increas
membran
environ
molecul
accomod
get
pack
inde
arb
appar
affin
toe
liposom
membran
mm
rang
valu
compar
fusion
arb
affin
even
greater
membran
peptid
contain
trp
tyrosin
tyr
residu
ca
mm
due
indol
group
conceiv
arb
might
display
select
indol
ring
trp
gener
aromat
group
phenol
ring
tyr
greater
number
arb
molecul
could
therefor
interact
aromat
residu
peptid
sequenc
lead
cooper
quench
effect
overal
larger
appar
affin
nmr
structur
synthet
peptid
hcv
bvdv
peptid
report
refer
respect
solubil
tag
kkgg
ggkk
nand
ctermin
end
indic
ital
aromat
residu
trp
tyr
indic
bold
underlin
b
peptidetolipid
molar
ratio
although
hcv
entri
inhibit
arb
found
genotypedepend
hcv
membran
fusion
inhibit
arb
genotypeindepend
manner
hcv
entri
fusion
earli
step
life
cycl
viru
hcv
first
interact
envelop
glycoprotein
set
coreceptor
plasma
membran
level
recent
review
eventu
becom
endocytos
due
combin
action
acidif
endosom
particular
lipid
like
cholesterol
sphingomyelin
viral
fusion
occur
broad
spectrum
ph
rang
hcv
bind
hepatocyt
membran
follow
endocytosi
therefor
requir
sever
cellular
protein
like
involv
sever
level
interact
interact
viral
protein
cellular
viral
protein
viralcellular
protein
lipid
featur
might
explain
differenti
effect
exert
arb
entri
variou
hcv
genotyp
inde
subtl
differ
protein
sequenc
could
translat
modifi
interact
sever
partner
andor
sever
level
convers
common
principl
action
appli
fusion
reaction
viral
fusion
cellular
fusion
process
alik
inde
fusion
process
involv
two
partner
lipid
fusion
protein
might
account
similar
inhibitori
effect
arb
hcv
fusion
observ
genotyp
line
observ
arb
display
potent
antivir
activ
antigen
serotyp
influenza
virus
previous
notic
arb
inhibit
primari
infect
cell
hcv
clone
effici
cell
preincub
arb
infect
addit
inhibit
hcvpp
happ
cell
entri
effici
arb
preincub
viral
cell
membran
use
vitro
fusion
assay
observ
arb
inhibit
hcvpp
fusion
maxim
viral
target
membran
incub
arb
fusion
initi
suggest
certain
level
membran
impregn
andor
satur
arb
must
achiev
effici
inhibit
viral
infect
membran
might
therefor
act
concentr
arbidol
high
concentr
molecul
might
local
achiev
could
explain
arb
exhibit
appar
medium
low
affin
membran
mm
rang
exert
relev
antivir
activ
without
notic
membran
damag
along
line
spite
mark
membranotrop
arb
display
low
toxic
arb
exhibit
compar
micromolar
appar
affin
aromat
residu
present
membran
peptid
membran
environ
altogeth
observ
lead
us
propos
mechanist
model
way
arb
would
inhibit
hcv
entri
fusion
membranotrop
arb
abl
freeli
interact
viral
target
membran
could
local
get
highli
concentr
arb
also
abl
interact
aromat
residu
within
viral
protein
involv
membran
interact
membran
destabil
necessari
fusion
dual
bind
capac
arb
could
local
imped
structur
rearrang
requir
fusion
protein
adopt
fusion
conform
fact
arb
activ
mm
rang
suggest
arb
would
act
reduc
overal
speed
fusion
reaction
rather
block
specif
protein
conform
could
therefor
explain
broad
antivir
spectrum
arb
genotyp
independ
inhibitori
effect
hcv
fusion
sinc
hcv
envelop
protein
contain
wellconserv
aromat
residu
genotyp
mechanist
key
point
rel
access
residu
arb
membran
interfac
cooper
effect
arb
sever
aromat
residu
might
therefor
occur
also
local
environ
aromat
aa
import
sinc
presenc
residu
histidin
vicin
could
modifi
access
respect
ph
interestingli
enough
sequenc
hcv
peptid
studi
tabl
shown
involv
hcv
fusion
contigu
trp
peptid
surround
three
tyrosin
concept
critic
ph
sensor
key
intramolecular
domain
interfac
viral
fusion
protein
recent
emerg
inde
proton
sole
e
protein
tickborn
enceph
flaviviru
tbev
trigger
largescal
conform
chang
lead
viral
fusion
concern
hcv
rey
cowork
recent
propos
model
arrang
ectodomain
model
fusion
looppeptid
would
lie
within
poorli
structur
domain
ii
peptid
would
found
global
unstructur
domain
iii
critic
residu
dispos
interfac
domain
put
fusion
loop
contain
phenylalanin
tyrosin
low
ph
optim
ph
hcv
membran
fusion
key
histidin
could
becom
proton
could
result
conform
rearrang
context
arb
fusion
inhibit
aromat
residu
might
consequ
becom
less
access
arb
molecul
present
vicin
note
appar
affin
arb
hcv
peptid
weaker
ph
ph
low
ph
arb
also
proton
proton
form
could
exhibit
greater
prefer
interfaci
region
lipid
bilay
deproton
form
demonstr
adamantan
combin
notion
key
aromat
residu
would
also
display
interfaci
local
low
ph
would
turn
explain
higher
effici
arb
inhibit
fusion
acid
ph
conclus
data
reveal
arb
directli
interact
lipid
membranewat
interfac
abl
bind
aromat
residu
present
hcv
glycoprotein
membraneassoci
form
subtl
bind
interplay
arb
lipid
viral
cellular
protein
arb
might
effici
block
hcv
entri
membran
fusion
interact
main
actor
earli
step
viral
entri
interestingli
arb
inhibit
process
demonstr
affin
mm
rang
although
membranotrop
properti
arb
suggest
could
becom
local
concentr
membran
togeth
find
suggest
arb
could
increas
strength
viral
glycoprotein
interact
membran
due
dual
bind
mode
involv
aromat
residu
phospholipid
result
complex
would
inhibit
expect
viral
glycoprotein
conform
chang
requir
membran
fusion
process
antivir
mechan
arb
therefor
open
promis
perspect
develop
small
membranotrop
low
affin
molecul
would
becom
local
concentr
membran
would
mainli
act
kinet
conform
rearrang
viral
fusion
protein
figur
arb
inhibit
infect
membran
fusion
dosedepend
manner
infect
result
mean
sem
separ
experi
black
arb
blue
mm
green
mm
red
mm
arb
respect
b
membran
fusion
hcvpp
genotyp
liposom
lipid
mix
kinet
follow
fluoresc
spectroscopi
use
excit
emiss
nm
respect
fluoresc
liposom
mm
final
lipid
concentr
ad
ml
hcvpp
pb
ph
absenc
presenc
indic
concentr
arb
minequilibr
lipid
mix
initi
decreas
ph
dilut
hcl
dequench
record
maxim
fluoresc
obtain
addit
final
triton
averag
valu
last
fusion
ie
final
extent
fusion
use
calcul
percentag
fusion
presenc
arb
rel
fusion
without
arb
figur
black
arb
blue
mm
green
mm
red
mm
arb
respect
tif
increas
concentr
arb
mm
top
bottom
trp
emiss
fluoresc
measur
nm
excit
nm
appar
affin
arb
toward
trp
calcul
plot
differ
da
area
curv
auc
peptid
without
arb
da
auc
arb
arb
function
arb
concentr
insert
tif
